Počet záznamov: 1
Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival
Názov Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival Autor Urbanová Mária SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV Spoluautori Cihová Marína 1984- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV Buociková Verona SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV Slopovsky J. Dubovan Peter Pinďák Daniel Tomáš Miroslav Bermejo L. G. Rodríguez-Garrote Mercedes Earl Julie Kohl Yvonne Kataki A. Dušinská Mária Sainz Bruno Smolková Božena 1968- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV SCOPUS RID ORCID Gábelová Alena 1955- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV SCOPUS ORCID Zdroj.dok. Biomedicine & Pharmacotherapy. Vol. 165 (2023), art. no. 115179 Jazyk dok. eng - angličtina Krajina FR - Francúzsko Poznámky open access URL URL link Druh dok. rozpis článkov z periodík (rbx) Ohlasy YU, P.F. - WEI, J.L. - LIU, P. - BIAN, J.D. - ZHANG, Q. - ZHOU, S. - LUO, Q.K. - ZHANG, X. - FU, Q. - ZHANG, H.W. - QIN, T. MGLL Coordinates YWHAZ to Mediate Gemcitabine Resistance in Pancreatic Cancer via IL6/PI3K/AKT Signaling Pathway. In JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS. ISSN 0393-974X, DEC 2023, vol. 37, no. 12, p. 7087-7104. Dostupné na: https://doi.org/10.23812/j.biol.regul.homeost.agents.20233712.668. IZZADEEN, A. - DYMOCK, L. - HOSKINS, C. Small-scale particles showing large-scale impact in pancreatic cancer. In NANOMEDICINE. ISSN 1743-5889, OCT 2023, vol. 18, no. 25, p. 1795-1797. Dostupné na: https://doi.org/10.2217/nnm-2023-0283. BHATTACHARYA, Sankha - BENINGER, Paul. The Emerging Role of Cell Membrane-coated Nanomaterials in Cancer Therapy. In Current Pharmaceutical Design, 2024-01-01, 30, 10, pp. 727-741. ISSN 13816128. Dostupné na: https://doi.org/10.2174/0113816128295414240221063434. CHEN, Yuhang - CHENG, Chien Shan - YANG, Peiwen - DONG, Shu - CHEN, Lianyu. Novel silicene-mesoporous silica nanoparticles conjugated gemcitabine induced cellular apoptosis via upregulating NF-κB p65 nuclear translocation suppresses pancreatic cancer growth in vitro and in vivo. In Nanotechnology, 2024-06-17, 35, 25, pp. ISSN 09574484. Dostupné na: https://doi.org/10.1088/1361-6528/ad312a. ZHOU, Xintao - ZHENG, Zhenjiang - YANG, Jianchen - CHEN, Yin - LI, Mengfei - SILLI, Epiphane K. - TANG, Jiali - MA, Yang - MA, Guimeng - ZONG, Yihao - YU, Lingxi - GUO, Ruizhe - HOU, Guilin - TAN, Chunlu - WANG, Ying. Development of cationic pH-sensitive liposomes with Gemcitabine loading and Fucoidan-coating against pancreatic cancer cells. In Journal of Drug Delivery Science and Technology, 2024-10-01, 100, pp. ISSN 17732247. Dostupné na: https://doi.org/10.1016/j.jddst.2024.106035. WANG, Yumin - LIU, Shiqian - WANG, Yan - LI, Baibei - LIANG, Jiaming - CHEN, Yu - TANG, Bo - YU, Shuiping - WANG, Hongquan. KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1/YAP to induce lipid accumulation in pancreatic ductal adenocarcinoma. In Cell Death Discovery, 2024-12-01, 10, 1, pp. Dostupné na: https://doi.org/10.1038/s41420-024-02020-4. Kategória ADCA - Vedecké práce v zahraničných karentovaných časopisoch impaktovaných Kategória (od 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Typ výstupu článok Rok vykazovania 2023 Registrované v WOS Registrované v SCOPUS Registrované v CCC DOI 10.1016/j.biopha.2023.115179 
článok
Názov súboru Prístup Veľkosť Stiahnuté Typ Licence Nanomedicine and epigeneticsNew alliances to increase the odds in pancreatic cancer survival.pdf Prístupný 1.5 MB 2 Vydavateľská verzia rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2023 2022 7.5 Q1 1.366 Q1
Počet záznamov: 1